Adenosine and cerebral ischemia: therapeutic future or death of a brave concept?

By Von Lubitz D.K.J.E.  

European Journal of Pharmacology, Vol. 365, Iss. 1, 1999-01 ,pp. : 9-25

Elsevier

Access to resources Recommend Favorite

Commentary: Death Associated Protein Kinase 1: A Perp in Cerebral Ischemia

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 8, 2016-09 ,pp. : 874-877

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Manipulation of Brain Glycogenolysis as a Therapeutic Approach to Cerebral Ischemia

By  

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 12, 2010-10 ,pp. : 1188-1193

Bentham Science Publishers

Access to resources Recommend Favorite

The Potential Roles of Metallothionein as a Therapeutic Target for Cerebral Ischemia and Retinal Diseases

By  

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 4, 2013-01 ,pp. : 400-407

Bentham Science Publishers

Access to resources Recommend Favorite

Adenosine A 1 Receptor Enhancer, PD 81,723, and Cerebral Ischemia/Reperfusion Injury in the Gerbil

By Cao X.   Phillis J.W.  

General Pharmacology, Vol. 26, Iss. 7, 1995-11 ,pp. : 1545-1548

Elsevier

Access to resources Recommend Favorite